Titre : | The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy |
Revue : | Human molecular genetics, 28, 13 |
Auteurs : | Guiraud S, Auteur ; Edwards B ; Babbs A ; Squire SE ; Berg A ; Moir L ; Wood MJ ; Davies KE |
Type de document : | Article |
Année de publication : | 01/07/2019 |
Pages : | p 2189 |
Note générale : |
Correction to: The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
This is a correction to “The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy,” Human Molecular Genetics, Volume 28, Issue 13, 1 July 2019, Pages 2189–2200, https://doi.org/10.1093/hmg/ddz049 In October 2019, the first author provided an updated Figure 1, which was embedded into the online version of the article, and the text below was added to the figure caption online. The journal is now issuing a correction notice to highlight this change more prominently to readers. “Publisher's note: Two frames in Panel A of Figure 1 were mounted the wrong way round when this paper was first published online. The image for mdx-Fergie utrophin has been moved to the mdx-Fergie merge location and vice versa. The image for mdx-Fiona utrophin has been moved to the mdx-Fiona merge location and vice versa. These changes do not affect the conclusion and an updated figure has been published to replace the original.” |
Langues: | Anglais |
Mots-clés : | dystrophie musculaire de Duchenne ; dystrophine ; prise en charge thérapeutique ; souris modèle ; utrophine |
Pubmed / DOI : | DOI : 10.1093/hmg/ddz049 / Pubmed : 30990876 / Pubmed : 37668344 / DOI : 10.1093/hmg/ddad145 |
N° Profil MNM : | 2019042 |
En ligne : | http://www.ncbi.nlm.nih.gov/pubmed/30990876 |